Gene · 3148
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a glycolysis-related diagnostic model for osteoarthritis through integrated bioinformatics analysis and machine learning. | J Orthop Surg Res | 2025 | 40646535 | PubTator, text mining | PubMed |
| Transcriptional programs underlying human monocyte differentiation and diversity. | J Leukoc Biol | 2025 | 40631795 | PubTator, text mining | PubMed |
| SLC7A1, SGK1 and HMGB2 are overexpressed in cervical cancer tissues and the miR‑23b‑3p/HMGB2 axis regulates cell migration and invasion. | Mol Med Rep | 2025 | 40576131 | PubTator, text mining | PubMed |
| Single-cell analysis of heterogeneity and molecular changes in cultured corneal epithelial stem cells during serial passage. | Stem Cells | 2025 | 40574692 | PubTator, text mining | PubMed |
| Identification of DNA damage repair-related diagnostic markers for idiopathic pulmonary fibrosis via WGCNA. | Comput Biol Chem | 2025 | 40570466 | PubTator, text mining | PubMed |
| Single-Cell Profiling of the Microenvironment in High-Risk Neuroblastoma. | IUBMB Life | 2025 | 40536225 | PubTator, text mining | PubMed |
| High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors. | Virchows Arch | 2025 | 40518465 | PubTator, text mining | PubMed |
| Characterization of m6A-Related Genes in Tumor-Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms. | FASEB J | 2025 | 40474570 | PubTator, text mining | PubMed |
| Pan-cancer analysis of phagocytosis regulators in female-specific cancers: a focus on HMGB2. | Front Immunol | 2025 | 40396172 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31+ glioma cells. | Transl Cancer Res | 2025 | 40386270 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics? | Ann Rheum Dis | 2025 | 40374430 | PubTator, text mining | PubMed |
| Circulating HMGB2 Is Associated With Angiographic Coronary Collateralization in Diabetic Patients With Chronic Total Occlusion and Impairs Vessel Growth via NLRP3. | Circ J | 2025 | 40368806 | PubTator, text mining | PubMed |
| Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma. | Sci Adv | 2025 | 40315321 | PubTator, text mining | PubMed |
| LINC00534 promotes breast cancer progression by targeting the miR-139-5p/HMGB2 axis. | Discov Oncol | 2025 | 40314851 | PubTator, text mining | PubMed |
| Phase separation of MRG15 delays cellular senescence. | Commun Biol | 2025 | 40312521 | PubTator, text mining | PubMed |
| Hmgb2 improves astrocyte to neuron conversion by increasing the chromatin accessibility of genes associated with neuronal maturation in a proneuronal factor-dependent manner. | Genome Biol | 2025 | 40247387 | PubTator, text mining | PubMed |
| Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19. | J Med Virol | 2025 | 40183283 | PubTator, text mining | PubMed |
| Predictive and clinicopathological importance of HMGB2 in various carcinomas: a meta and bioinformatic approach. | Sci Rep | 2025 | 40164660 | PubTator, text mining | PubMed |
| Intratumoral Heterogeneity and Immune Microenvironment in Hepatoblastoma Revealed by Single-Cell RNA Sequencing. | J Cell Mol Med | 2025 | 40099956 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3148/papers?page=5